lamivudine and zidovudine

FDA Drug Profile — LAMIVUDINE AND ZIDOVUDINE, COMBIVIR

Drug Details

Generic Name
lamivudine and zidovudine
Brand Names
LAMIVUDINE AND ZIDOVUDINE, COMBIVIR
Application Number
ANDA203259
Sponsor
XLCare Pharmaceuticals, Inc
NDC Codes
2
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
LAMIVUDINE, ZIDOVUDINE

Indications and Usage

1 INDICATIONS & USAGE Lamivudine and zidovudine tablets a combination of 2 nucleoside analogues, are indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Lamivudine and zidovudine tablets, a combination of 2 nucleoside analogue reverse transcriptase inibitors, are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. (1)